Day: January 15, 2022

IX Asia Indexes Announces the Results of the ixCrypto Index Quarterly Review (2021 Q4)logoixCrypto.jpg

HONG KONG SAR – Media OutReach – 15 January 2022 – Today, IX Asia Indexes Company Limited announced the 4th quarter review of the ixCrypto Index (“IXCI”). This is the first crypto benchmark index launched in Hong Kong.  The number of constituent cryptos remains unchanged at 11 constituents after the review. The free float adjusted market capitalization coverage […]

CStone announces the clinical data from registrational study of Sugemalimab in stage III non-small cell lung cancer published in The Lancet Oncology

SUZHOU, China, Jan. 15, 2022 /PRNewswire/ — CStone Pharmaceuticals (“CStone”, HKEX: 2616), a leading biopharmaceutical company focused on research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today announced that the registrational clinical data from sugemalimab (the GEMSTONE-301 study) in stage III non-small cell lung cancer (NSCLC) were published in the world-leading clinical […]

CStone announces the registrational clinical study results of sugemalimab in stage IV non-small cell lung cancer published in The Lancet Oncology

SUZHOU, China, Jan. 15, 2022 /PRNewswire/ — CStone Pharmaceuticals (“CStone”, HKEX: 2616), a leading biopharmaceutical company focused on research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today announced that results of the GEMSTONE-302 study, a randomized double-blind registrational clinical study for sugemalimab as the first-line treatment of stage IV non-small cell lung […]

French Consul General in Guangzhou led a delegation to visit Biosyngen in China-Singapore Guangzhou Knowledge City

GUANGZHOU, ChinaJan. 15, 2022 /PRNewswire/ — On the afternoon of January 14th, Mr. Sylvain FOURRIERE, Consul General of France in Guangzhou, and officers from consulates general of 9 countries including Britain, Canada and Switzerland visited China-Singapore Guangzhou Knowledge City and Singapore-based Biosyngen Pte. Ltd. (“Biosyngen”). Government representatives from Guangzhou Foreign Affairs Office, Huangpu District, Guangzhou Development District, China-Singapore […]

Back To Top